PDMR Dealing

RNS Number : 6923L

Oncimmune Holdings PLC

14 January 2021

 

Oncimmune Holdings plc

("Oncimmune" or the "Company")

PDMR Dealing

Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, has been notified on 13 January 2021 that Genostics Company Limited ("Genostics"), a Person Closely Associated ("PCA") (as that term is defined in the EU Market Abuse Regulation ("MAR")) with Dr Cheung To, a Non-Executive Director of the Company, has sold ordinary shares of £0.01 each in the Company ("Ordinary Shares") as follows:

Date	No Ordinary Shares	Price (£)
11 December 2020	10,000	1.65
14 December 2020	30,000	1.675
21 December 2020	5,000	1.70
5 January 2021	50,000	1.70
5 January 2021	50,000	1.75
8 January 2021	10,000	1.85
11 January 2021	40,000	1.85
Total	195,000

Following this transaction, Genostics has a total interest in the Company of 6,215,256 Ordinary Shares, representing approximately 9.8 per cent. of the Company's issued Ordinary Share capital.    

This announcement, including the notification below, is made in accordance with the requirements of Article 19 of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Genostics Company Limited
2	Reason for the notification
a)	Position/status	PCA of Dr Cheung To, Non-Executive Director of the Company
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.65	10,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	11 December 2020
f)	Place of the transaction	London stock exchange, AIM
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.675	30,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	14 December 2020
f)	Place of the transaction	London stock exchange, AIM
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.70	5,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	21 December 2020
f)	Place of the transaction	London stock exchange, AIM
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.70	50,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	5 January 2021
f)	Place of the transaction	London stock exchange, AIM
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.75	50,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	5 January 2021
f)	Place of the transaction	London stock exchange, AIM
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.85	10,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	8 January 2021
f)	Place of the transaction	London stock exchange, AIM
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)
			Price	Volume
			£1.85	40,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	11 January 2021
f)	Place of the transaction	London stock exchange, AIM

For further information:

Oncimmune Holdings plc

Ron Kirschner, General Counsel and Company Secretary

[e-mail]    

 

END

 

 

DSHDKQBQCBKKFDD